Clinical-stage drug company RXi Pharmaceuticals Corp. reported on Thursday it has kept its ongoing cash burn in line with projections while moving development programs forward and closing in on a recently announced acquisition.
Holliston's Biostage will need to raise more money to get to human trials of its bioengineered organ implants to treat throat cancers as its third quarter losses exceed $3 million with a little over $6 million left in cash on hand.
The second-largest healthcare provider in the state is making moves to extended outside of its Eastern Massachusetts stronghold through a new partnership with a 200 physician independent practice association based in Central Massachusetts.
A state commission says it is working to measure the impacts associated with Steward Health Care Network's proposed acquisition of a 200-physician independent practice association.
The value of the parent company for Saint Vincent Hospital in Worcester and MetroWest Medical Center in Framingham dropped more than 25 percent in morning trading on Wednesday.